This is a preview of subscription content, log in via an institution to check access.
Notes
Trial Assigning IndividuaLized Options for treatment (Rx).
The researchers were from the University of New Mexico School of Medicine, TriCore Reference Labs, InLight Solutions and VeraLight.
References
National Cancer Institute. Personalized treatment trial for breast cancer launched. Media release: 23 May 2006
Paik S, Tang G, Shak S, et al. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptorpositive breast cancer. J Clin Oncol 2006 May 23. (Epub ahead of print)
Genomic Health. Genomic Health announces ‘early release’ publication of NSABP study confirming Oncotype DX predicts chemotherapy benefit in certain breast cancer patients. Media release: 23 May 2006
Genomic Health. The National Surgical Adjuvant Breast and Bowel Project (NSABP) and Genomic Health, Inc. announce positive early results in development of genomic test for colon cancer prognosis. Media release: 4 Jun 2006
VeraLight. Study shows new non-invasive device screens diabetes better than fasting plasma glucose test. Media release: 12 Jun 2006
diaDexus. diaDexus announces issued U.S. patent for Lp-PLA2 activity-based atherosclerosis diagnostic test. Media release: 30 May 2006
ExonHit Therapeutics. ExonHit files patent on a panel of genes for the diagnosis of Alzheimer’s disease from blood. Media release: 19 May 2006
Rights and permissions
About this article
Cite this article
Diagnostic Developments. Pharmaceutical & Diagnostic Innovation 4, 17–19 (2006). https://doi.org/10.1007/BF03257082
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03257082